Indicators

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Today 16:12 EDT

Novartis posts better-than-expected first-quarter sales, raises full-year guidance

April 29, 2025

5 things to know before the stock market opens Monday

April 28, 2025

Cramer's week ahead: Key economic data and earnings from Apple, Amazon, Meta and Microsoft

April 25, 2025

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

April 25, 2025

Corporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses

April 23, 2025

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

April 23, 2025

Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients

April 17, 2025

Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs

April 16, 2025

Pfizer scraps daily weight loss pill after liver injury in one patient

April 14, 2025

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

April 11, 2025

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’

April 09, 2025

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

April 09, 2025

Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind

April 09, 2025

Trump says tariffs will accelerate reshoring, but experts say it's not that easy

April 05, 2025

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

April 04, 2025

Europe's pharma industry braces for tariffs as carve-out hopes fade

April 02, 2025

Hims & Hers shares rise as company adds new weight-loss medications to platform

April 01, 2025

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up

April 01, 2025

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

April 01, 2025

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

March 29, 2025

Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'

March 28, 2025

Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action

March 27, 2025

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

March 25, 2025

5 things to know before the stock market opens Tuesday

March 25, 2025

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer

March 24, 2025

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

March 24, 2025

Beijing pledges greater market access as top global CEOs gather at the China Development Forum

March 24, 2025

Zepbound copycats remain online despite FDA ban

March 21, 2025

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.